NCT03021278

Brief Summary

The purpose of this study is to determine whether experimentally induced acute low back pain might lead to alteration in lumbar tactile acuity measured in region affected by pain compared to pain-free side and pain-free controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

January 9, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 13, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

July 31, 2017

Status Verified

July 1, 2017

Enrollment Period

5 months

First QC Date

January 9, 2017

Last Update Submit

July 27, 2017

Conditions

Keywords

Tactile acuityChronic painTwo-point discriminationPoint-to-point testTwo-point estimationBody image

Outcome Measures

Primary Outcomes (1)

  • Lumbar tactile acuity measured by two-point discrimination test (TPD).

    Mechanical callipers will be delicately applied to the pre-marked axis until the very first blanching of the skin. Testing will be commenced with 0 mm between the two calliper's tips, and then the distance between them will be gradually increased until participants will able to verbally report that two points had been touched instead of one. Subsequently, the descending sequence will be applied until the perception of the two points disappeared.

    Measured an average 3 minutes after manipulation (e.g. saline injection).

Secondary Outcomes (5)

  • Pain intensity measured behaviourally on a Numerical Rating Scale (NRS).

    Pain intensity will be measured just after saline/sham injection and every 30 seconds after this time point up until 12 minutes.

  • Distribution of pain measured by estimating the diameter of the circle representing area affected by pain. Greater circle (diameter) will refer to the greater distribution of pain (larger body surface affected).

    Pain distribution will be measured just after saline/sham injection and every 30 seconds after this time point up until 12 minutes.

  • Fear of pain measured on a Numerical Rating Scale (NRS).

    Fear of pain measured only at baseline

  • Lumbar tactile acuity measured by point-to-point test (PTP).

    PTP measured at baseline (1), an average 3 minutes after manipulation (2) (e.g. saline injection) and 12 minutes after manipulation (3)

  • Lumbar tactile acuity measured by two-point estimation test (TPE)

    PTP measured at baseline (1), an average 3 minutes after manipulation (2) (e.g. saline injection) and 12 minutes after manipulation (3)

Other Outcomes (2)

  • Fear of Pain Questionnaire (FPQ-III).

    Measured only at baseline

  • Pain Catastrophizing Scale (PCS).

    Measured only at baseline

Study Arms (3)

Saline Injection

EXPERIMENTAL

In the saline injection group, low back pain will be induced via 1.0 ml hypertonic (5% NaCl).

Other: Saline injection

Sham Injection

EXPERIMENTAL

In the sham injection group, a real needle will be shown to the participants to imitate and produce the anticipation of a pain experience.

Other: Sham injection

Control Group

NO INTERVENTION

The control group will not receive any kind of pain or pinprick sensation.

Interventions

In the saline injection group, low back pain will be induced via 1.0 ml hypertonic (5% NaCl) saline bolus injection which is a commonly used model of acute low back pain. Saline will be injected into the right (or left) lumbar longissimus muscle 50 mm lateral to the spinous process just above (5 mm) previously marked point. Injections will be performed by a physician under ultrasound imaging guidance to ensure that each single injection will be equally placed at a depth of 30 mm. The side for the pain induction will be randomised across subjects. The place of needle insertion and corresponding point on the opposite side of the body will be covered by placing a small piece of adhesive plaster.

Also known as: Experimental pain
Saline Injection

In the sham-injection group (placebo comparator), a real needle will be shown to the participants to imitate and produce the anticipation of a pain experience. A pinprick sensation will be produced by a weighted stimulus applied perpendicularly to the skin just above without piercing the skin. A stimulus of 512 mN will be used to produce a pinprick sensation and activation of cutaneous nociceptors. Adhesive tapes covering stimulation points will also be provided.

Also known as: Sham pain
Sham Injection

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Only participants with similar mechanical detection threshold (MDT) on both sides of the spine will be included.

You may not qualify if:

  • sex: female
  • age \< 18 or \> 35 years
  • laterality: left-handed
  • current pain experience
  • episodes of back pain lasting more than 24 hours within the previous one-month period
  • history of chronic pain, i.e. pain lasting more than one-month
  • comorbidities affecting the nervous system
  • cardio-vascular diseases
  • psychiatric illnesses
  • any disease requiring systematic drug consumption.
  • diagnosed hypersensitive reaction to saline solution

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Jerzy Kukuczka Academy of Physical Education

Katowice, 40-065, Poland

Location

Related Publications (5)

  • Adamczyk W, Slugocka A, Saulicz O, Saulicz E. The point-to-point test: A new diagnostic tool for measuring lumbar tactile acuity? Inter and intra-examiner reliability study of pain-free subjects. Man Ther. 2016 Apr;22:220-6. doi: 10.1016/j.math.2015.12.012. Epub 2016 Jan 2.

    PMID: 26797175BACKGROUND
  • Catley MJ, O'Connell NE, Berryman C, Ayhan FF, Moseley GL. Is tactile acuity altered in people with chronic pain? a systematic review and meta-analysis. J Pain. 2014 Oct;15(10):985-1000. doi: 10.1016/j.jpain.2014.06.009. Epub 2014 Jun 28.

    PMID: 24983492BACKGROUND
  • Tsao H, Tucker KJ, Coppieters MW, Hodges PW. Experimentally induced low back pain from hypertonic saline injections into lumbar interspinous ligament and erector spinae muscle. Pain. 2010 Jul;150(1):167-172. doi: 10.1016/j.pain.2010.04.023. Epub 2010 May 26.

    PMID: 20510516BACKGROUND
  • Wand BM, Di Pietro F, George P, O'Connell NE. Tactile thresholds are preserved yet complex sensory function is impaired over the lumbar spine of chronic non-specific low back pain patients: a preliminary investigation. Physiotherapy. 2010 Dec;96(4):317-23. doi: 10.1016/j.physio.2010.02.005.

    PMID: 21056167BACKGROUND
  • Adamczyk WM, Saulicz O, Saulicz E, Luedtke K. Tactile acuity (dys)function in acute nociceptive low back pain: a double-blind experiment. Pain. 2018 Mar;159(3):427-436. doi: 10.1097/j.pain.0000000000001110.

Related Links

MeSH Terms

Conditions

Acute PainLow Back PainChronic Pain

Interventions

Sodium Chloridesalicylhydroxamic acid

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBack Pain

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Wacław M Adamczyk, Msc

    The Jerzy Kukuczka Academy of Physical Education

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

January 9, 2017

First Posted

January 13, 2017

Study Start

January 1, 2017

Primary Completion

June 1, 2017

Study Completion

July 1, 2017

Last Updated

July 31, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations